Health Bulletin 23/December/2022

Published On 2022-12-23 11:12 GMT   |   Update On 2022-12-25 12:30 GMT
Advertisement

Here are the top health stories for the day:

Gurugram hospital conducts India's first 3-way liver transplant swap, saves 3 lives

Doctors at Gurugram-based Medanta Hospital have successfully performed the country's first three-way transplant swap, in which three patients simultaneously received life-saving liver transplants. The patients were suffering from terminal liver failure, each needing an urgent liver transplant to survive. 

Check out the Medical Dialogues official site for more health news:

https://medicaldialogues.in/


The surge of COVID-19 in China-should it be a cause of concern for indians?

The recent unprecedented surge in Covid cases in China has sent Alarm Bells ringing worldwide. Govt of India has too has expressed concerns. Fear and Panic seem to be driving the masses. Govt acting with an abundance of caution can be justified, but there seems little cause for worry for vaccinated healthy citizens in India. But How? Let's analyze.

Better Immunity among Indians?

Widespread infection by Sars-CoV-2 during the second wave of Covid-19 in India has given solid immunity to Indians.

For more details, check out the link given below:

The Surge Of COVID-19 In China-Should It Be A Cause Of Concern For Indians?

NMC gives deadline to all medical colleges to submit MBBS admissions info online

The Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) recently directed all the medical colleges/institutes to submit the details of the students who got admitted in the MBBS course during the academic year 2022-2023.

NMC issued such a direction to ensure that all the MBBS admissions have been made while adhering to the judicial decisions and MCI / NMC Regulations, to make sure that no admission has been made beyond intake capacity, and eligibility criteria, qualifying marks specified under the Regulation on Graduate Medical Education, 1997 are being followed.

For more details, check out the link given below:

NMC Gives Deadline To All Medical Colleges To Submit MBBS Admissions Info Online


IPCA labs, Cadila Healthcare among 16 Indian Pharma Firms blacklisted in Nepal

In a major setback, Nepal has banned import of medicines from 16 Indian pharmaceutical companies including IPCA Laboratories, Cadila Healthcare, Baba Ramdev promoted Divya Pharmacy for allegedly failing to comply with the World Health Organization's (WHO) Good Manufacturing Practices (GMP).

Nepal's Department of Drug Administration has released a list of 16 Indian pharmaceutical companies. IPCA Labs in South Sikkim and Ahmedabad-based Cadila Healhcare have also been mentioned in the list that do not comply regulatory compliance apart from Divya Pharmacy, which is part of yoga guru Ramdev's business conglomerate Patanjali Ayurved.

For more details, check out the link given below:

IPCA Labs, Cadila Healthcare Among 16 Indian Pharma Firms Blacklisted In Nepal

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News